Anavex Life Sciences Corp (AVXL)

[McMagyar]

It is early Alzheimers
The progression of the disease varies greatly at the early stage.
It is very possible that some patients will not have deteriorated after 48 months..

In the placebo arm whatever that number is.. simply deduct that number from the
responders in the 30mg cohort and the 50mg cohort..

So if 5 out of 170 placebo consort are. Close to baseline..


And 85 from the 30 Mg cohort are at baseline or above.. reduce that number to 80..

And when 170 of theb50 Mg are at baseline of above you reduce that to 165..


Making the number 245 out of 330 are at or above baseline due to Blarcamesine..

Why argue minutiae? The meat of the data will leave zero doubt only adulation and joy and
will make these arguments pointless for the shorts.